Serum LRG1 as a non-invasive biomarker for identifying complex coronary anatomy in pre-angiography risk stratification - Summary - MDSpire

Serum LRG1 as a non-invasive biomarker for identifying complex coronary anatomy in pre-angiography risk stratification

  • By

  • Zhengkai Yang

  • Zirui Liu

  • Ying Xu

  • Haocheng Wang

  • Yu Lu

  • Cao Zou

  • June 4, 2026

  • 0 min

Share

Objective:

To investigate whether LRG1 is an independent risk factor for complex coronary lesions and to explore if a combined model with LDL-C could improve predictive performance.

Key Findings:
  • Significant overexpression of LRG1 in AMI patients compared to non-AMI patients.
  • Higher serum LRG1 concentrations in individuals with SYNTAX Scores ≥ 23 compared to those with Scores < 23 (P < 0.001).
  • LRG1 and LDL-C identified as independent predictors of elevated SYNTAX Score ≥ 23.
  • Logistic regression model showed moderate discriminatory ability (AUC = 0.771) and excellent calibration (P = 0.416).
Interpretation:

Limitations:
  • Single-center observational study may limit generalizability.
  • Retrospective design and reliance on de-identified samples.
Conclusion:

Preliminary evidence suggests that serum LRG1 could be a useful biomarker for assessing complex coronary anatomy prior to angiography.

Original Source(s)

Related Content